Greenphire Named One of the Fastest-Growing U.S Companies
News Aug 21, 2013
The company has been ranked 192, and 21 in the software industry, on the seventh annual list which represents the most comprehensive look at America's independent entrepreneurs.
Sam Whitaker, CEO, Greenphire, comments: "We are delighted to have made this year's Inc. 500. The Greenphire team has worked relentlessly to achieve our success and we are proud to have joined the ranks with many of the nation's most high achieving and innovative companies."
Since Greenphire was founded in 2008, the business has gone from strength-to-strength, launching two groundbreaking clinical payment technologies and securing contracts with multiple top 30 pharmaceutical companies. In the past 12 months alone, Greenphire has more than doubled its team and has established strategic partnerships with a number of leading organizations.
Scientists Report The Development of a Potent New Medicine to Fight AddictionNews
Scientists report the development of a potent new medicine to fight addiction.READ MORE
Minoryx Therapeutics spins off SEE-Tx platform into new company, Gain TherapeuticsNews
The new Swiss company will operate in Lugano and Barcelona under the scientific management of Minoryx co-founder Dr Xavier Barril.READ MORE
Lonza Expands Encapsulation and HPAPI Capabilities in North AmericaNews
Expanding our capabilities into commercial-scale encapsulation responds to our customers' desire to maintain programs at the Tampa, FL (USA) site from clinical development to commercialization.READ MORE